Page last updated: 2024-08-22

tricalcium phosphate and Hypertrophy, Left Ventricular

tricalcium phosphate has been researched along with Hypertrophy, Left Ventricular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q1
Culleton, B; Hemmelgarn, B; Klarenbach, S; Manns, BJ; Tonelli, M; Walsh, M1
Bhandari, S1
Böhm, M; Cremers, B; Ege, P; Fehrenz, M; Fliser, D; Heine, GH; Hornof, F; Jeken, J; Kersting, S; Rebling, NM; Rogacev, KS; Scheller, B; Seiler, S; Steimle, C1
Culleton, BF; Donnelly, S; Friedrich, MG; Hemmelgarn, BR; Klarenbach, SW; Kumar, A; Mahallati, H; Manns, BJ; Mortis, G; Quinn, RR; Scott-Douglas, N; Tonelli, M; Walsh, M1

Reviews

1 review(s) available for tricalcium phosphate and Hypertrophy, Left Ventricular

ArticleYear
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease.
    Frontiers in bioscience (Landmark edition), 2011, 01-01, Volume: 16, Issue:4

    Topics: Albuminuria; Anemia, Iron-Deficiency; Calcium Phosphates; Carnitine; Heart Failure; Homocysteine; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism Disorders; Myocarditis; Oxidative Stress; Proteinuria; Risk Factors; Vitamin D Deficiency

2011

Trials

2 trial(s) available for tricalcium phosphate and Hypertrophy, Left Ventricular

ArticleYear
The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2010, Volume: 14, Issue:2

    Topics: Adult; Aged; Appointments and Schedules; Calcinosis; Calcium; Calcium Phosphates; Circadian Rhythm; Combined Modality Therapy; Female; Hemodialysis, Home; Humans; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphates; Risk Factors

2010
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
    JAMA, 2007, Sep-19, Volume: 298, Issue:11

    Topics: Adult; Aged; Anemia; Blood Pressure; Calcium Phosphates; Circadian Rhythm; Erythropoietin; Female; Hematocrit; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Parathyroid Hormone; Quality of Life; Renal Dialysis

2007

Other Studies

2 other study(ies) available for tricalcium phosphate and Hypertrophy, Left Ventricular

ArticleYear
High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
    Nutrients, 2016, Oct-20, Volume: 8, Issue:10

    Topics: Adult; Calcium Phosphates; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Incidence; Kidney; Linear Models; Male; Middle Aged; Prevalence; Renal Insufficiency, Chronic; Risk Factors; Serum Albumin; Sex Factors; Uric Acid; Ventricular Dysfunction, Left

2016
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
    European heart journal, 2011, Volume: 32, Issue:21

    Topics: Atrial Fibrillation; Biomarkers; Calcium Phosphates; Coronary Artery Disease; Cross-Sectional Studies; Electrocardiography; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hypertrophy, Left Ventricular; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Dysfunction, Left

2011